Canalization and plasticity in psychopathology
This theory-building paper (2022) introduces a new model of psychopathology called canalization, which is a form of plasticity that relates to increased model precision. It suggests that TEMP, combined with psychological support, can counter the entrenchment of canalization in pathological phenotypes, and offers suggestions for experiments to test its main hypotheses and implications.
Authors
- Fernando Rosas
- Richard Zeifman
- Robin Carhart-Harris
Published
Abstract
This theoretical article revives a classical bridging construct, canalization, to describe a new model of a general factor of psychopathology. To achieve this, we have distinguished between two types of plasticity, an early one that we call ‘TEMP’ for ‘Temperature or Entropy Mediated Plasticity’, and another, we call ‘canalization’, which is close to Hebbian plasticity. These two forms of plasticity can be most easily distinguished by their relationship to ‘precision’ or inverse variance; TEMP relates to increased model variance or decreased precision, whereas the opposite is true for canalization. TEMP also subsumes increased learning rate, (Ising) temperature and entropy. Dictionary definitions of ‘plasticity’ describe it as the property of being easily shaped or molded; TEMP is the better match for this. Importantly, we propose that ‘pathological’ phenotypes develop via mechanisms of canalization or increased model precision, as a defensive response to adversity and associated distress or dysphoria. Our model states that canalization entrenches in psychopathology, narrowing the phenotypic statespace as the agent develops expertise in their pathology. We suggest that TEMP - combined with gently guiding psychological support - can counter canalization. We address questions of whether and when canalization is adaptive versus maladaptive, furnish our model with references to basic and human neuroscience, and offer concrete experiments and measures to test its main hypotheses and implications.
Research Summary of 'Canalization and plasticity in psychopathology'
Introduction
Carhart-Harris and colleagues revive the biological concept of canalization to propose a parsimonious, transdiagnostic model of psychopathology. They contrast canalization — the development of stable, low-variance phenotypes — with forms of plasticity that increase phenotypic variability. Central to their framing is precision (inverse variance): canalization corresponds to increased precision and reduced sensitivity to new evidence, whereas a distinct form of plasticity they introduce, TEMP (Temperature or Entropy Mediated Plasticity), corresponds to decreased precision, increased variance, and higher learning rates. This distinction is used to reinterpret how entrenched cognitive and behavioural styles can develop and persist after adversity, distress or dysphoria. The paper sets out to do three things. First, it develops a theoretical model (CANAL) that treats the general psychopathology or 'p' factor as arising from entrenched canalized phenotypes. Second, it links this model to existing computational frameworks (notably the free-energy principle) and a specific mechanistic account of psychedelic action (the REBUS model), arguing that transient increases in TEMP can enable a simulated-annealing-like reconfiguration of maladaptive attractors. Third, the authors map this framework onto existing basic and clinical neuroscience findings, propose candidate biomarkers and experimental paradigms to test the model, and discuss clinical implications — including how psychedelic therapy plus supportive psychotherapy might counteract canalization.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typemeta
- Journal
- Authors
- APA Citation
Carhart-Harris, R., Chandaria, S., Erritzoe, D., Gazzaley, A., Girn, M., Kettner, H., Mediano, P., Nutt, D., Rosas, F., Roseman, L., Timmermann, C., Weiss, B., Zeifman, R., & Friston, K. (2023). Canalization and plasticity in psychopathology. Neuropharmacology, 226, 109398. https://doi.org/10.1016/j.neuropharm.2022.109398
References (57)
Papers cited by this study that are also in Blossom
Agin-Liebes, G. I., Zeifman, R. J., Luoma, J. B. et al. · Journal of Psychopharmacology (2022)
Alamia, A., Timmermann, C., Carhart-Harris, R. L. · eLife (2020)
Alnefeesi, Y., Chen-Li, D., Jawad, M. Y. et al. · Journal of Psychiatric Research (2022)
Atasoy, S., Leor, R., Kaelen, M. et al. · Scientific Reports (2017)
Brouwer, A., Carhart-Harris, R. L. · Journal of Psychopharmacology (2020)
Buchborn, T., Schröder, H., Höllt, V. et al. · Journal of Psychopharmacology (2014)
Calder, A. E., Hasler, G. · Neuropsychopharmacology (2022)
Carhart-Harris, R. L. · Neuropharmacology (2018)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
Show all 57 referencesShow fewer
Carhart-Harris, R. L., Kaelen, M., Whalley, M. G. et al. · Psychopharmacology (2014)
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M. et al. · Psychological Medicine (2016)
Carhart-Harris, R. L., Erritzoe, D., Haijen, E. C. H. M. et al. · Psychopharmacology (2017)
Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)
Davis, A. K., Barrett, F. S., Griffiths, R. R. · Journal of Contextual Behavioral Science (2020)
Daws, R. E., Timmermann, C., Giribaldi, B. et al. · Nature Medicine (2022)
Doss, M. K., Považan, M., Rosenberg, M. D. et al. · Translational Psychiatry (2021)
Erritzoe, D., Smith, J. M., Fisher, P. M. et al. · Journal of Psychopharmacology (2019)
Fattore, L., Piva, A., Zanda, M. T. et al. · Psychopharmacology (2017)
Forstmann, M., Sagioglou, C. · Journal of Psychopharmacology (2017)
Girn, M., Roseman, L., Bernhardt, B. et al. · NeuroImage (2022)
Goodwin, G. M., Aaronson, S. T., Alvarez, O. et al. · New England Journal of Medicine (2022)
Griffiths, R. R., Hurwitz, E. S., Davis, A. K. et al. · PLOS ONE (2019)
Hendricks, P. S., Thorne, C. B., Clark, B. et al. · Journal of Psychopharmacology (2015)
Hipólito, I., Mago, J., Rosas, F. E. et al. · Psyarxiv (2022)
Jobst, B. M., Atasoy, S., Ponce-Alvarez, A. et al. · NeuroImage (2021)
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. et al. · Journal of Psychopharmacology (2014)
Kaelen, M., Barrett, F. S., Roseman, L. et al. · Psychopharmacology (2015)
Kanen, J. W., Luo, Q., Kandroodi, M. R. et al. · Psychological Medicine (2020)
Kaplan, A. L., Confair, D. N., Kim, K. et al. · Nature (2022)
Kim, K., Che, T., Panova, O. et al. · Cell (2020)
Kočárová, C., Horacek, J., Carhart-Harris, R. L. · Frontiers in Psychiatry (2021)
Yehuda, R., Lepow, L., Morishita, H. · Frontiers in Neuroscience (2021)
Lord, L. D., Expert, P., Atasoy, S. et al. · NeuroImage (2019)
Lu, J., Tjia, M., Mullen, B. et al. · Molecular Psychiatry (2021)
Ly, C., Greb, A. C., Cameron, L. P. et al. · Cell Reports (2018)
Lyons, T., Carhart-Harris, R. L. · Journal of Psychopharmacology (2018)
Mans, K., Kettner, H., Erritzoe, D. et al. · Frontiers in Psychiatry (2021)
Mason, N. L., Kuypers, K. P. C., Reckweg, J. et al. · Neuropsychopharmacology (2020)
Mitchell, J., Bogenschutz, M. P., Lilienstein, A. et al. · Nature Medicine (2021)
Murphy, R., Murphy-Beiner, A., Kettner, H. et al. · Frontiers in Pharmacology (2022)
Murphy-Beiner, A., Soar, K. · Psychopharmacology (2020)
Nardou, R., Lewis, E. M., Rothhaas, R. et al. · Nature (2019)
Nour, M. R., Evans, J., Carhart-Harris, R. L. · Journal of Psychoactive Drugs (2017)
Nygart, V., Pommerencke, L. M., Haijen, E. et al. · Journal of Psychopharmacology (2022)
Olson, J. A. · Neuroscience Insights (2018)
Peill, J. M., Trinci, K. E., Kettner, H. et al. · Journal of Psychopharmacology (2022)
Ruffini, G., Damiani, G., Lozano-Soldevilla, D. et al. · PLOS ONE (2023)
Schartner, M., Carhart-Harris, R. L., Barrett, A. B. et al. · Scientific Reports (2017)
Shao, L-X,, Liao, C., Gregg, I. et al. · Neuron (2021)
Singleton, S. P., Luppi, A. I., Carhart-Harris, R. L. et al. · Nature Communications (2022)
Tagliazucchi, E., Roseman, L., Kaelen, M. et al. · Current Biology (2016)
Timmermann, C., Kettner, H., Letheby, C. et al. · Scientific Reports (2021)
Timmermann, C., Watts, R., Dupuis, D. · Transcultural Psychiatry (2022)
Watts, R., Day, C. M., Krzanowski, J. et al. · Journal of Humanistic Psychology (2017)
Nygart, V., Pommerencke, L. M., Carhart-Harris, R. L. et al. · Frontiers in Psychology (2021)
Weiss, B., Miller, J. D., Carter, N. T. et al. · Scientific Reports (2021)
Cited By (23)
Papers in Blossom that reference this study
Johansen, A., Plavén-Sigray, P., Madsen, M. K. et al. · Research Square (2025)
Henry, J., Giribaldi, B., Nutt, D. J. et al. · European Neuropsychopharmacology (2025)
Lissemore, J. I., Chaiken, A., Keller, C. J. et al. · Nature Mental Health (2025)
Wießner, I., Falchi-Carvalho, M., Laborde, S. et al. · European Neuropsychopharmacology (2025)
Wall, M. B., Demetriou, L., Giribaldi, B. et al. · American Journal of Psychiatry (2025)
Harding, R., Singer, N., Wall, M. B. et al. · Molecular Psychiatry (2025)
Safron, A., Juliani, A., Reggente, N. et al. · Neuroscience of Consciousness (2025)
Mathai, D. S., Roberts, D. E., Nayak, S. M. et al. · Journal of Psychedelic Drugs (2025)
Lyons, T., Spriggs, M. J., Kerkelä, L. et al. · Biorxiv (2024)
Erritzoe, D., Barba, T., Greenway, K. T. et al. · EClinicalMedicine (2024)
Show all 23 papersShow fewer
Lewis, E. C., Jaeger, A., Girn, M. et al. · Journal of Psychopharmacology (2024)
Juliani, A., Chelu, V., Graesser, L. et al. · Biorxiv (2024)
Peill, J. M., Marguilho, M., Erritzoe, D. et al. · Journal of Psychopharmacology (2024)
Erritzoe, D., Barba, T., Spriggs, M. J. et al. · Journal of Psychopharmacology (2024)
Weiss, B., Leor Roseman, •., Giribaldi, B. et al. · International Journal of Mental Health and Addiction (2024)
Copa, D., Erritzoe, D., Giribaldi, B. et al. · Journal of Affective Disorders (2024)
Erritzoe, D., Timmermann, C., Godfrey, K. et al. · Nature Mental Health (2024)
Agin-Liebes, G. I., Nielson, E. M., Zingman, M. et al. · Psychology of Addictive Behaviors (2024)
Argyri, E. K., Evans, J., Luke, D. et al. · SSRN (2024)
Rosas, F. E., Mediano, P. A. M., Timmermann, C. et al. · Biorxiv (2023)
Bremler, R., Katati, N., Shergill, P. et al. · Scientific Reports (2023)
Vohryzek, J., Cabral, J., Timmermann, C. et al. · National Science Review (2023)
Zeifman, R. J., Wagner, A. C., Monson, C. M. et al. · Journal of Affective Disorders (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.